tm logo
TAVALISSE
REGISTERED

on 08 Jul 2019

Last Applicant/ Owned by

RIGEL PHARMACEUTICALS INC.

1180 Veterans BoulevardSan Francisco, CA 94080

US

Serial Number

1823324 filed on 17th Feb 2017

Registration Number

TMA1037634 registered on 08th Jul 2019

Registration expiry Date

08th Jul 2029

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

TAVALISSE

Trademark usage description

pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, inflammatory bowel disease, coeliac disease, ulcerative colitis; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders, namely, thrombocytopenia, leukemia, autoimmune hemolytic anemia.


Classification kind code

11

Mark Details


Serial Number

1823324

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 21st Dec 2018
Allowed
Submitted for opposition 51
on 21st Dec 2018
Allowance Notice Sent
Submitted for opposition 42
on 05th Sep 2018
Advertised
Submitted for opposition 26
on 16th Aug 2018
Approved
Submitted for opposition 27
on 27th Jun 2018
Approval Notice Sent
Submitted for opposition 22
on 11th Dec 2017
Search Recorded
Submitted for opposition 20
on 11th Dec 2017
Examiner's First Report
Submitted for opposition 31
on 21st Feb 2017
Formalized
Submitted for opposition 30
on 17th Feb 2017
Filed
Submitted for opposition 1
on 17th Feb 2017
Created